Clinical Trial Update: A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study comparing vaginal and intravenous administration of oxytocin in participants with vaginal atrophy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Atrophy

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: PepTonic Medical AB | Conditions: Vaginal Atrophy | Phase 2 | Status: COMPLETED